Hypoxia, HIF1 and glucose metabolism in the solid tumour - PubMed
Review
Hypoxia, HIF1 and glucose metabolism in the solid tumour
Nicholas C Denko. Nat Rev Cancer. 2008 Sep.
Abstract
It has been known for many years that cellular metabolism within the solid tumour is markedly different from that of the corresponding normal tissue. The transcription factor hypoxia-inducible factor 1 (HIF1) has been implicated in regulating many of the genes that are responsible for the metabolic difference. However, it remains unclear how this 'aerobic glycolysis', originally described by Otto Warburg, offers tumour cells a growth advantage. As discussed in this Perspective, new data suggests that this metabolic switch may provide a benefit to the tumour not by increasing glycolysis but by decreasing mitochondrial activity.
Similar articles
-
Causes and Consequences of A Glutamine Induced Normoxic HIF1 Activity for the Tumor Metabolism.
Kappler M, Pabst U, Weinholdt C, Taubert H, Rot S, Kaune T, Kotrba J, Porsch M, Güttler A, Bache M, Krohn K, Bull F, Riemann A, Wickenhauser C, Seliger B, Schubert J, Al-Nawas B, Thews O, Grosse I, Vordermark D, Eckert AW. Kappler M, et al. Int J Mol Sci. 2019 Sep 24;20(19):4742. doi: 10.3390/ijms20194742. Int J Mol Sci. 2019. PMID: 31554283 Free PMC article.
-
Effects of hypoxia on tumor metabolism.
Kim JW, Gao P, Dang CV. Kim JW, et al. Cancer Metastasis Rev. 2007 Jun;26(2):291-8. doi: 10.1007/s10555-007-9060-4. Cancer Metastasis Rev. 2007. PMID: 17415528 Review.
-
Zwaans BM, Lombard DB. Zwaans BM, et al. Dis Model Mech. 2014 Sep;7(9):1023-32. doi: 10.1242/dmm.016287. Epub 2014 Aug 1. Dis Model Mech. 2014. PMID: 25085992 Free PMC article. Review.
-
Regulation of cancer cell metabolism by hypoxia-inducible factor 1.
Semenza GL. Semenza GL. Semin Cancer Biol. 2009 Feb;19(1):12-6. doi: 10.1016/j.semcancer.2008.11.009. Epub 2008 Dec 9. Semin Cancer Biol. 2009. PMID: 19114105 Review.
-
Tumour glycolysis: the many faces of HIF.
Kelly C, Smallbone K, Brady M. Kelly C, et al. J Theor Biol. 2008 Sep 21;254(2):508-13. doi: 10.1016/j.jtbi.2008.05.025. Epub 2008 May 29. J Theor Biol. 2008. PMID: 18639251
Cited by
-
BNIP3 is degraded by ULK1-dependent autophagy via MTORC1 and AMPK.
Park CW, Hong SM, Kim ES, Kwon JH, Kim KT, Nam HG, Choi KY. Park CW, et al. Autophagy. 2013 Mar;9(3):345-60. doi: 10.4161/auto.23072. Epub 2013 Jan 4. Autophagy. 2013. PMID: 23291726 Free PMC article.
-
Parthenolide targets NF-κB (P50) to inhibit HIF-1α-mediated metabolic reprogramming of HCC.
Liu X, Gao Z, Wang X, Shen Y. Liu X, et al. Aging (Albany NY). 2022 Oct 18;14(20):8346-8356. doi: 10.18632/aging.204339. Epub 2022 Oct 18. Aging (Albany NY). 2022. PMID: 36260873 Free PMC article.
-
Management of Advanced Pancreatic Cancer through Stromal Depletion and Immune Modulation.
Liu T, Cheng S, Xu Q, Wang Z. Liu T, et al. Medicina (Kaunas). 2022 Sep 17;58(9):1298. doi: 10.3390/medicina58091298. Medicina (Kaunas). 2022. PMID: 36143975 Free PMC article. Review.
-
Temporal regulation of HIF-1 and NF-κB in hypoxic hepatocarcinoma cells.
Jiang Y, Zhu Y, Wang X, Gong J, Hu C, Guo B, Zhu B, Li Y. Jiang Y, et al. Oncotarget. 2015 Apr 20;6(11):9409-19. doi: 10.18632/oncotarget.3352. Oncotarget. 2015. PMID: 25823824 Free PMC article.
-
Loss of HIF-1α accelerates murine FLT-3(ITD)-induced myeloproliferative neoplasia.
Velasco-Hernandez T, Tornero D, Cammenga J. Velasco-Hernandez T, et al. Leukemia. 2015 Dec;29(12):2366-74. doi: 10.1038/leu.2015.156. Epub 2015 Jun 24. Leukemia. 2015. PMID: 26104662
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials